UTHealth Houston, in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health), has been awarded $50 million from the Texas Health and Human Services Commission to lead a collaborative two-year, multicenter research trial that will evaluate the effect of ibogaine on patients suffering from addiction, traumatic brain injury, and other behavioral health conditions.
